Jeff Dunkel

Originally from Memphis, Jeff serves as the CEO of Optain Heath. Jeff’s experience spans from startup clinics to research institutions, includes smaller device companies to Fortune 500 healthcare mainstays, and has involved successful exit strategies of acquisitions and divestitures. His contracting strategies, which included accountability for patient outcomes and cost guarantees, have been recognized by Forbes magazine for leading the industry in risk share arrangements.

Jeff led efforts to create new CMS technology categories and eight Section X ICD-10pcs codes for a previously unrecognized area of orthopaedic medical devices. He holds an advisory role with the US Department of Health and Human Services Center for Clinical Innovation, sits on the Executive Committee for the Food and Drug Administration-sponsored Medical Device Epidemiology Network, assisted in authoring the FDA’s PREPT task force report, is a mentor for small businesses working with the National Institute of Health, held two former population health advisory roles with the White House, is a board member for the Center of Global Health Innovation’s Health Equity and Crisis Coordination division, chairs Mindset Medicals Strategic Advisory Board, and actively contributes to national legislation language with members of Congress and the Senate.

Jeff has served previously as the CSO at Mindset Medical, the EVP of Strategy at Titan Spine (exited to Medtronic), CEO of NuHope, and the President’s Advisory Committee for Johnson and Johnson’s laboratory division. Jeff holds a Bachelor of Science from the School of Public Health at Indiana University, where he spent three years in pre-med studies and two in business studies.